How to reduce the risk of cardiotoxicity in pediatric cancer survivors? | FISSAC

For the Healthy Science Community

Physiology , Health

9 minutes

October 1, 2018

How to reduce the risk of cardiotoxicity in pediatric cancer survivors?

Written by Javier S. Morales

Long -lasting pediatric cancer survivors have 5 times more risk of death due to cardiovascular disease than the population without pathology, especially due to the use of cardiotoxic treatments such as anthracyclines. The limited success and adverse factors of the pharmacological treatments used to minimize the damage of anthracyclines must lead us to look for alternative strategies

To access all content, subscribe to FISSAC.

Now with 40% during the first year

🎁 Annual

You pay € 3/month

59,99€

35,99€

/year

Annual billing.

Now all the advantages of FISSAC with a 40% discount the first year . Instead of € 59.99, you pay only € 35.99.

Monthly

You pay € 72/year

6€

/month

Monthly billing.

Access all the content that Fissac offers unlimitedly. You can cancel your subscription without any commitment.

Cancel your subscription whenever you want without obligation. Offer for an annual FISSAC subscription; only available for new subscribers. For a monthly subscription, the rate of € 6.00 each month will be automatically charged to its payment method. For an annual subscription, the introductory rate of € 35.99 and subsequently the usual rate of € 59.99 each year will be automatically charged to its payment method. Your subscription will continue until you cancel it. The cancellation enters into force at the end of its current billing period. Taxes included in the subscription price. The terms of the offer are subject to changes.

Access all the information of our plans and prices .

You are not Fissac yet? Here are these free access items to think about it 😌

Free access

9 minutes

The month in which you were born conditions your chances of success

Written by Javier S. Morales

Free access

8 minutes

High performance | Physiology

Smell ammonia, useful to improve performance?

Written by Pedro L. Valenzuela

What do Fissac subscribers think?

"FISSAC+ is the temple of physiology applied to health and sports performance. The scientific experience behind your human team, together with the rigor and the constant update of content, make this space a true reference in the field. "

"Fissac Academy is the definitive learning resource for those who seek solid knowledge and based on science about physiology, nutrition and sports. Knowledge pills, designed by experts in the field, make learning easy and attractive.

Hello! Access your account.